Name: AstraZeneca Pharma India Ltd. Financial Filings and Reports
Creator: FinancialReports
License: https://financialreports.eu/terms/

Filings indexed 1,263 across all filing types

Latest filing 2023-05-30 Regulatory Filings

Country IN India

Listing BSE.NS ASTRAZEN

About AstraZeneca Pharma India Ltd.

https://www.astrazeneca.com/content/az-…

AstraZeneca Pharma India Ltd. is a science-led biopharmaceutical organization dedicated to the discovery, development, and commercialization of innovative prescription medicines. The company focuses on core therapeutic areas including Oncology, Cardiovascular, Renal & Metabolism, Respiratory & Immunology, and Rare Disease. Its product portfolio includes advanced treatments such as Tagrisso, Lynparza, and Imfinzi for various cancers, as well as Forxiga and Brilinta for metabolic and cardiovascular conditions. The company utilizes a robust global research pipeline to address complex medical challenges and improve patient outcomes. Through clinical research and specialized healthcare solutions, it delivers transformative therapies designed to treat chronic and life-threatening diseases. The organization is characterized by its commitment to scientific excellence and the delivery of high-value medical interventions.

Recent filings

Filing	Released	Lang
Publish Audited Results Regulatory Filings	2023-05-30	English
The Board of Directors of the Company at its Meeting held today i.e., May 30, 2023, has inter-alia: 1. Approved the Audited Financial Results of the Company for the quarter and .... Regulatory Filings	2023-05-30	English
The Board of Directors of the Company at its Meeting held today i.e., May 30, 2023, has inter-alia: 1. Approved the Audited Financial Results of the Company for the quarter and .... Regulatory Filings	2023-05-30	English
Annual Secretarial Compliance Report Regulatory Filings	2023-05-26	English
In terms of SEBI's Circular No. CIR/CFD/CMD1/27/2019 dated February 8, 2019, we furnish herewith the Secretarial Compliance Report, for the year ended March 31, 2023. Please take the .... Regulatory Filings	2023-05-26	English
Loss of Share Certificates Regulatory Filings	2023-05-25	English

Browse filings by year

17 years

	ID	Filing	Released	Lang
2023 15 filings
	42869012	Publish Audited Results Regulatory Filings	2023-05-30	English
	46008530	The Board of Directors of the Company at its Meeting held today i.e., May 30, 2023, has inter-alia: 1. Approved the Audited Financial Results of the Company for the quarter and .... Regulatory Filings	2023-05-30	English
	46008538	The Board of Directors of the Company at its Meeting held today i.e., May 30, 2023, has inter-alia: 1. Approved the Audited Financial Results of the Company for the quarter and .... Regulatory Filings	2023-05-30	English
	42982766	Annual Secretarial Compliance Report Regulatory Filings	2023-05-26	English
	46008533	In terms of SEBI's Circular No. CIR/CFD/CMD1/27/2019 dated February 8, 2019, we furnish herewith the Secretarial Compliance Report, for the year ended March 31, 2023. Please take the .... Regulatory Filings	2023-05-26	English
	42806886	Loss of Share Certificates Regulatory Filings	2023-05-25	English
	46008532	Pursuant to Regulation 39(3) and other applicable regulations of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the Registrar .... Regulatory Filings	2023-05-25	English
	43985772	Board Meeting — ASTRAZENECA PHARMA INDIA LIMITED has informed the Exchange about Board Meeting to be held on 30-May-2023 to consider and approve the Yearly Audited Financial results of the Company fo… Regulatory Filings	2023-05-22	English
	43985760	Board Meeting — Financial Results/Dividend Regulatory Filings	2023-05-22	English
	46008535	ASTRAZENECA PHARMA INDIA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2023 ,inter alia, to consider and approve 1. The Audited Financial .... Board/Management Information	2023-05-22	English
	42870242	Loss of Share Certificates Regulatory Filings	2023-05-15	English
	46008536	Pursuant to Regulation 39(3) and other applicable regulations of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the Registrar .... Regulatory Filings	2023-05-15	English
	42874302	Certificate under SEBI (Depositories and Participants) Regulations, 2018 Regulatory Filings	2023-05-08	English
	46008537	We are enclosing herewith the Certificate dated May 5, 2023 issued by Integrated Registry Management Services Private Limited, Registrar and Transfer Agents (RTA) of the Company confirming .... Regulatory Filings	2023-05-08	English
	42841248	Updates Regulatory Filings	2023-05-03	English

Page 41 of 85

Prev … 39 40 41 42 43 … Next

Market data

Market data not available

Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products

2,202 peers

Company	Ticker	Country	Sector
13260917 Canada Inc. Biotech developing oral small molecules to restore muscle s…	MSCL	CA	Manufacturing
1608557 Ontario Inc. Biopharmaceutical company dedicated to R&D, discovery, and …	OTROQ	CA	Manufacturing
3B BlackBio Dx Limited Develops molecular diagnostic kits for oncology, infectious…	3BBLACKBIO	IN	Manufacturing
3D Medicines Inc. Commercial-stage biopharma specializing in next-generation …	1244	HK	Manufacturing
3SBio Inc. Biopharmaceutical enterprise specializing in R&D, productio…	1530	KY	Manufacturing
4BASEBIO PLC Manufactures GMP-grade synthetic DNA for next-generation th…	4BB	GB	Manufacturing
4D Molecular Therapeutics, Inc. Develops genetic medicines using AAV vectors for ophthalmol…	FDMT	US	Manufacturing
4Front Ventures Corp. Vertically integrated cannabis operator managing cultivatio…	FFNT	CA	Manufacturing
4SC AG Biopharmaceutical company with no products under developmen…	VSC	DE	Manufacturing
60 DEGREES PHARMACEUTICALS, INC. Develops and commercializes medicines for infectious diseas…	SXTP	US	Manufacturing

Page 1 of 221

1 2 3 … Next

AstraZeneca Pharma India Ltd. via the API

Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.

Get API access Read API reference

Base URLapi.financialreports.eu

Auth headerx-api-key

Company ID60656

TickerASTRAZEN

ISININE203A01020

Endpoints

most-used routes for this company

GET	/api/companies/60656/	Company identity, sector, listing, identifiers
GET	/api/filings/?company=60656	Paginated list of all filings (filterable by type, date, language)
GET	/api/filings/{id}/	Single filing — metadata, document URL, processing status
GET	/api/filings/{id}/markdown/	Filing content as Markdown (PDF → text/tables/figures)
GET	/api/isins/?company=60656	All ISINs registered to this company
GET	/api/filing-types/	Reference: every filing-type code + category

Full reference: API reference · OpenAPI schema

cURL

latest filings for AstraZeneca Pharma India Ltd.

$ curl https://api.financialreports.eu/api/filings/?company=60656 \
    -H "x-api-key: $FR_API_KEY" \
    -H "Accept: application/json"

Python

requests

import requests

r = requests.get(
    "https://api.financialreports.eu/api/filings/",
    params={"company": 60656},
    headers={"x-api-key": API_KEY},
)
filings = r.json()["results"]

MCP server

Claude · Claude Code · ChatGPT

Claude setup ChatGPT setup Claude Code setup

// MCP server URL
https://mcp.financialfilings.com/mcp

// Once connected, the LLM can query this company directly:
"Pull the latest 5 filings for AstraZeneca Pharma India Ltd. (id: 60656)"

AstraZeneca Pharma India Ltd. — Investor Relations & Filings